Efficacy and Safety of Topical Brepocitinib for the Treatment of Mild to Moderate Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomised, double-blind, vehicle-controlled, dose-ranging, and parallel-group study
Br J Dermatol 2022 Aug 20;[EPub Ahead of Print], MN Landis, M Arya, S Smith, Z Draelos, L Usdan, S Tarabar, V Pradhan, S Aggarwal, C Banfield, E Peeva, MS Vincent, V Sikirica, J Xenakis, JS BeebeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.